Solanbridge Group Inc Announces Addition of Wendy Coffin

HOUSTON, Oct. 21, 2014 /PRNewswire/ -- Solanbridge Group Inc (OTC: SLNX) is pleased to announce that its subsidiary Solanbridge Group Nova Scotia, Inc., has added Ms. Wendy Coffin to its Board of Directors.  She will act as the subsidiary's Medical Director.

Ms. Coffin joined the Board on October 1, 2014.  She will provide Solanbridge with invaluable medical and pharmaceutical experience.

Charles R. Shirley, CEO of Solanbridge, stated, "We welcome Ms. Wendy Coffin to Solanbridge.  Ms. Coffin will be working with Solanbridge to develop products in the emerging medical marijuana market."

About Wendy Coffin

Wendy is a practising Pharmacist and a business owner.  She is president and pharmacist manager of the Dartmouth Gate Pharmacy in Dartmouth, Nova Scotia.

Wendy serves on the Economic Committee for the Pharmacy Association of Nova Scotia. On this committee she deals with economic and business related issues including government negotiations. She was a participant in the provincial Minor Ailment Pilot Project, which was used to evaluate of the provision of minor ailment assessments and prescribing in the pharmacy setting.

Wendy is also involved with 'The Bloom Program" in alignment with Nova Scotia's Mental Health Strategy in which community pharmacies help to improve the quality of life for people with mental health and addictions.

Wendy brings two important attributes to Solanbridge: knowledge of both business and healthcare. Wendy earned an undergraduate degree in Biology from St. Francis Xavier University in 1996 and in Pharmacy from Dalhousie University in 2001.

About Solanbridge Group Inc

Solanbridge Group Inc, based in Greater Houston, is a diversified holding company looking to expand into the medical marijuana industry by developing commercial grower's licenses in Eastern Canadian medical marijuana jurisdictions, with the partnership of First Nations and developing CBD-infused products in Colorado and Nevada.  Solanbridge is also pursuing other acquisitions in the growing medical marijuana field and partnerships with agribusiness entities.

This release includes "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. These statements are based upon the current beliefs and expectations of Solanbridge's management and are subject to significant risks and uncertainties. There can be no guarantees with respect to that the products will prove to be commercially successful.  All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/solanbridge-group-inc-announces-addition-of-wendy-coffin-508198927.html

SOURCE Solanbridge Group Inc